| Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes A Scozzafava, F Briganti, MA Ilies, CT Supuran Journal of medicinal chemistry 43 (2), 292-300, 2000 | 207 | 2000 |
| Carbonic anhydrase inhibitors-Part 49: Synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I CT Supuran, A Scozzafava, BC Jurca, MA Ilies European journal of medicinal chemistry 33 (2), 83-93, 1998 | 204 | 1998 |
| Synthesis and Retrostructural Analysis of Libraries of AB3 and Constitutional Isomeric AB2 Phenylpropyl Ether-Based Supramolecular Dendrimers V Percec, M Peterca, MJ Sienkowska, MA Ilies, E Aqad, J Smidrkal, ... Journal of the American Chemical Society 128 (10), 3324-3334, 2006 | 193 | 2006 |
| Development of sulfonamide carbonic anhydrase inhibitors CT Supuran, A Casini, A Scozzafava Carbonic anhydrase, 79-160, 2004 | 187* | 2004 |
| Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives MA Ilies, D Vullo, J Pastorek, A Scozzafava, M Ilies, MT Caproiu, ... Journal of medicinal chemistry 46 (11), 2187-2196, 2003 | 179 | 2003 |
| Carbonic anhydrase inhibitors—part 52. Metal complexes of heterocyclic sulfonamides: a new class of strong topical intraocular pressure-lowering agents in rabbits CT Supuran, F Mincione, A Scozzafava, F Briganti, G Mincione, MA Ilies European journal of medicinal chemistry 33 (4), 247-254, 1998 | 173 | 1998 |
| Carbonic anhydrase inhibitors—Part 29 1: Interaction of isozymes I, II and IV with benzolamide-like derivatives CT Supuran, MA Ilies, A Scozzafava European journal of medicinal chemistry 33 (9), 739-751, 1998 | 172 | 1998 |
| Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects A Casini, A Scozzafava, F Mincione, L Menabuoni, MA Ilies, CT Supuran Journal of medicinal chemistry 43 (25), 4884-4892, 2000 | 167 | 2000 |
| Lipophilic pyrylium salts in the synthesis of efficient pyridinium-based cationic lipids, gemini surfactants, and lipophilic oligomers for gene delivery MA Ilies, WA Seitz, BH Johnson, EL Ezell, AL Miller, EB Thompson, ... Journal of medicinal chemistry 49 (13), 3872-3887, 2006 | 144 | 2006 |
| Endothelial targeting of antibody-decorated polymeric filomicelles VV Shuvaev, MA Ilies, E Simone, S Zaitsev, Y Kim, S Cai, A Mahmud, ... ACS nano 5 (9), 6991-6999, 2011 | 125 | 2011 |
| Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity MA Ilies, B Masereel, S Rolin, A Scozzafava, G Câmpeanu, V Cı̂mpeanu, ... Bioorganic & medicinal chemistry 12 (10), 2717-2726, 2004 | 115 | 2004 |
| Pyridinium cationic lipids in gene delivery: a structure− activity correlation study MA Ilies, WA Seitz, I Ghiviriga, BH Johnson, A Miller, EB Thompson, ... Journal of medicinal chemistry 47 (15), 3744-3754, 2004 | 111 | 2004 |
| Formation and Colloidal Stability of DMPC Supported Lipid Bilayers on SiO2 Nanobeads S Savarala, S Ahmed, MA Ilies, SL Wunder Langmuir 26 (14), 12081-12088, 2010 | 103 | 2010 |
| Synthetic nucleic acid delivery systems: present and perspectives B Draghici, MA Ilies Journal of medicinal chemistry 58 (10), 4091-4130, 2015 | 102 | 2015 |
| Carbonic anhydrase inhibitors—Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: the first non-polymeric membrane-impermeable inhibitors with … CT Supuran, A Scozzafava, MA Ilies, B Iorga, T Cristea, F Briganti, ... European journal of medicinal chemistry 33 (7-8), 577-594, 1998 | 97 | 1998 |
| Heterocyclic cationic gemini surfactants: a comparative overview of their synthesis, self‐assembling, physicochemical, and biological properties VD Sharma, MA Ilies Medicinal research reviews 34 (1), 1-44, 2014 | 95 | 2014 |
| Cationic lipids in gene delivery: principles, vector design and therapeutical applications M Ilies, WA Seitz, AT Balaban Current pharmaceutical design 8 (27), 2441-2473, 2002 | 91 | 2002 |
| Carbonic anhydrase activators: design of high affinity isozymes I, II, and IV activators, incorporating tri-/tetrasubstituted-pyridinium-azole moieties M Ilies, MD Banciu, MA Ilies, A Scozzafava, MT Caproiu, CT Supuran Journal of medicinal chemistry 45 (2), 504-510, 2002 | 87 | 2002 |
| Pyridinium cationic lipids in gene delivery: an in vitro and in vivo comparison of transfection efficiency versus a tetraalkylammonium congener MA Ilies, BH Johnson, F Makori, A Miller, WA Seitz, EB Thompson, ... Archives of biochemistry and biophysics 435 (1), 217-226, 2005 | 82 | 2005 |
| Carbonic anhydrases as disease markers S Zamanova, AM Shabana, UK Mondal, MA Ilies Expert opinion on therapeutic patents 29 (7), 509-533, 2019 | 78 | 2019 |
Andrea ScozzafavaProfessore di chimica, Università di Firenze確認したメール アドレス: unifi.it